Presented by
Almut G. Winestein, PhD
Professor & Chair of Pharmacy
University of Florida
Tandon Rajiv, MD
Executive Vice-Chair and Professor, Department of Psychiatry
University of Florida
Scott A. Teielbaum, MD, FAAP, DFASM
Professor and Vice Chair, Department of Psychiatry
University of Florida
William Green, MD
Assistant Professor, Department of Psychiatry
University of Florida
Target Audience
Primary Care Physicians
Price
$35.00
Program Description
This CME activity consists of an educational component (slides, audio lecture) in an electronic format, followed by an online post-test. Estimated time to complete this activity, including review of materials, is one hour.
Requirements for Successful Completion
Learning Objectives
As a result of participation in this activity, participants should be able to:
1. Define the pharmacological substrate of the physiological effects of cannabis.
2. Describe the potential medical benefits and potential risks of cannabis.
3. Appraise pros and cons in the medical use of cannabis today .
4. Evaluate challenges in the application of Florida's medical marijuana law .
Faculty Disclosure
Drs. Tandon, Teitelbaum, Greene and Winterstein have disclosed that they have no financial relationships to disclose. Dr. Bussing has disclosed that she has received research support from Pfizer. No one else in a position to control content has any financial relationships to disclose.
Continuing Medical Education Credit
Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit: The University of Florida College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Creditâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Release Date: June 28, 2017
Expiration Date: June 27, 2019